Computer navigation is a highly sophisticated tool in orthopedic surgery for component placement in total hip arthroplasty (THA). A number of recommendations have been published. Although Lewinnek's safe-zone is the best-known among these its significance is questioned in recent years since it addresses the acetabular socket only ignoring the femoral stem. Modern target definitions consider both socket and stem and provide well-defined recommendations for complementary component positioning. We present a new small-sized hand-held imageless navigation system that implies these targets and supports the surgeon in realizing the concept of combined anteversion and combined Target-Zone (cTarget- Zone) in THA and to control leg length and offset without altering the standard surgical work-flow and we report initial results. The targets for positioning the components of a total hip as expressed by radiographic cup inclination (cRI) and anteversion (cRA), stem antetorsion (sAT) and neck-to-shaft angle (sNSA) are determined for a specific prosthesis system using a computerized 3D-model. The optimizing goal is maximizing the size of the cSafe-Zone providing the largest target zone for an impingement-free prosthetic range of motion (pROM) in order to minimize the risk for dislocation in physiologic and combined movements. Independent parameters like head size, head-to-neck ration and also component orientations like cRI, cRA, sAT and sNSA were varied systematically and the optimal cSafe-Zone was computed in semi-automated batch runs. These optimized prosthesis-specific results were introduced into the software of the hand-held navigation system. This system measures leg length, offset, acetabular and femoral head centers intraoperatively.Introduction
Methods
The purpose of this study was to develop a cell-based VEGF gene therapy in order to accelerate fracture healing and investigate the effect of VEGF on bone repair in vivo. Twenty-one rabbits were studied. A ten millimeter segmental bone defect was created after twelve millimeter periosteal excision in the middle one third of each tibia and each tibia was plated. Primary cultured rabbit fibroblasts were transfected by use of SuperFect (Qiagen Inc) with pcDNA-VEGF. 5.0 X 106 cells in 1ml PBS were delivered via impregnated gelfoam into the fracture site. Experimental groups were:
Transfected fibroblasts with VEGF (n=7), Fibroblasts alone (n=7), and PBS only (n=7). The animals were sacrificed and fracture healing specimens collected at ten weeks post surgery Radiology: Fracture healing was defined as those with bone bridging of the fracture defect. After ten weeks, fourteen tibial fractures were healed in total including six in group one, four in group two and four in group three. The VEGF group had an earlier initial sufficient volume of bridging new bone formation. Histological evaluation demonstrated ossification across the entire defect in response to the VEGF gene therapy, whereas the defects were predominantly fibrotic and sparsely ossified in groups two and three. Numerous positively stained (CD31) vessels were shown in the VEGF group. MicroCT evaluation showed complete bridging for the VEGF group, but incomplete healing for groups two and three. Micro-CT evaluation of the new bone structural parameters showed that the amount of new bone (volume of bone (VolB) x bone mineral density (BMD)), bone volume fractions (BVF), bone volume/tissues (BV/TV), trabecular thickness (Tb.Th), number (Tb.N) and connectivity density (Euler number) were higher; while structure model index (SMI), bone surface/bone volume (BS/BV), and trabecular separations (Tb.Sp) were lower in the VEGF group than the other groups. P-Values <
0.05 indicated statistical significance (ANOVA, SPSS) in all parameters except for SMI (0.089) and VolBx-BMD (0.197). These results indicate that cell-based VEGF gene delivery has significant osteogenic and angiogenic effects and demonstrates the ability of cell based VEGF gene therapy to enhance healing of a critical sized defect in a long bone in rabbits.
This increased stiffness decreases motion under comparable loading conditions. In individuals who have excessive motion causing wrist symptoms, increasing the stiffness by capsular plication of the supporting ligaments decreases the motion to relieve symptoms. This technique has found success in clinical practice to relieve symptoms in patients with midcarpal instability.
Only someone with good common sense paired with a grain of fortune-telling might be able to foresee further improvements of THR implants adequately. After carefully reviewing the studies of the past, we have evolved our personal belief of what future improvements could look like. A new, improved stem should be made of titanium alloy, have a sandblasted surface structure with a tapered proximal fit stem design. Further advantages would be to allow a certain amount of bony restitution in the metaphyseal region and minimise the stress shielding effects on the femur. As an example of the often-difficult way from the idea on the drawing board to a commercially exploitable implant, we demonstrate the development of our newly designed “hollow-stem” prosthesis. In an animal study a tapered cementless hollow-stem prosthesis was implanted in 10 foxhounds and subsequently analysed after 12 and 24 weeks. As a result, mineralisation occurred between the titanium stays of the prosthesis, as well as in the central hollow area as early as two to four weeks after implantation. After 12 weeks, density of cancellous bone between the titanium stays and in the hollow centre was considerably higher than on the contralateral untreated side. Load bearing within the centre of the stem was obvious due to the regular orientation of the trabecular bone. After these positive results we began the conversion to a production line human stem prosthesis. With the help of a finite-element analysis, the stem was then modified in critical areas, resulting in an improved prototype which was subjected to a fatigue test according to ISO 7206-3 of 10.000.000 cycles without any damage. After careful deliberation with our ethics committee, we were finally able to commence with our pilot study consisting of the implantation of 20 hollow-stems and 20 Spotorno stems as a matched pairs study design. The clinical and radiological evaluation after a minimum 12-month follow-up shows comparably good clinical results in both groups. Radiologically, some degree of subsidence was seen in three hollow stems compared to two Spotorno stems without being clinically relevant. The next step will be a larger randomized study using the hollow-stem as well as a solid stem of the same design. We will consider a more widespread utilisation of the hollow-stem only if this randomised study proves the hollow-stem to be superior.